Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Microneedle patch could replace standard tuberculosis skin test

By R&D Editors | August 27, 2013

A chitin microneedle patch tested on human skin. Image: Marco Rolandi, UWEach year, millions of people in the U.S. get a tuberculosis skin test to see if they have the infection that still affects one-third of the world’s population. But the standard diagnostic test is difficult to give, because a hypodermic needle must be inserted at a precise angle and depth in the arm to successfully check for tuberculosis.

Now, a team led by Univ. of Washington engineers has created a patch with tiny, biodegradable needles that can penetrate the skin and precisely deliver a tuberculosis test. The researchers published their results online in Advanced Healthcare Materials.

“With a microneedle test there’s little room for user error, because the depth of delivery is determined by the microneedle length rather than the needle-insertion angle,” said senior author Marco Rolandi, a UW asst. prof. of materials science and engineering. “This test is painless and easier to administer than the traditional skin test with a hypodermic needle.”

A tuberculosis test is a common precautionary measure for teachers, health care professionals and international travelers. The bacterial infection usually attacks the lungs and can live in an inactive state for years in the body. A diagnostic test involves an injection in a person’s arm. Within two or three days, a swollen, firm bump will appear if an infection is present.

Rolandi’s laboratory and collaborators at the Infectious Disease Research Institute in Seattle believe this is the first time microneedles made from biomaterials have been used as a diagnostic tool for tuberculosis. They say their test will be easier to use, less painful and has the potential to be more successful than the standard tuberculosis skin test.

The researchers tested the patch on guinea pigs and found that after the microneedles were inserted using the patch, the skin reaction associated with having a tuberculosis infection was the same as when using the standard hypodermic needle test. A microneedle patch test has potential as a simpler, more reliable option than the traditional tuberculosis test for children who are needle-shy, or in developing countries where medical care is limited, Rolandi said.

“It’s like putting on a bandage,” Rolandi said. “As long as the patch is applied on the skin, the test is always delivered to the same depth underneath the skin.”

With the standard test, if a hypodermic needle is inserted at the wrong angle, the solution to check for tuberculosis is injected too deep or too shallow into the skin, and the test fails.

Microneedles have been used in recent years as a painless alternative to hypodermic needles to deliver drugs to the body. Microneedles on a patch can be placed on an arm or leg, which then create small holes in the skin’s outermost layer, allowing the drugs coated on each needle to diffuse into the body.

Microneedles are made from silicon, metals and synthetic polymers, and most recently of natural, biodegradable materials such as silk and chitin, a material found in hard outer shells of some insects and crustaceans.

The UW team developed microneedles made from chitin that are each 750 um long. Each needle tip is coated with purified protein derivative, the material used for testing for tuberculosis. The researchers found that these microneedles were strong enough to penetrate the skin and deliver the tuberculosis test.

“It’s a great application of this technology and I hope it will become a commercial product,” said paper co-author Darrick Carter, a biochemist and a vice president at the Infectious Disease Research Institute.

The researchers will continue developing the microneedle tuberculosis test and plan to test it next on humans. They also hope to develop different diagnostic tests using microneedles, including allergy tests.

Source: Univ. of Washington

Related Articles Read More >

Eli Lilly facility
9 R&D developments this week: Lilly builds major R&D center, Stratolaunch tests hypersonic craft, IBM chief urges AI R&D funding
professional photo of wooly mammoth in nature --ar 2:1 --personalize sq85hce --v 6.1 Job ID: 47185eaa-b213-4624-8bee-44f9e882feaa
Why science ethicists are sounding skepticism and alarm on ‘de-extinction’
ALAFIA system speeds complex molecular simulations for University of Miami drug research
3d rendered illustration of the anatomy of a cancer cell
Funding flows to obesity, oncology and immunology: 2024 sales data show where science is paying off
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE